Asensus Surgical, Inc. (ASXC)
| Market Cap | 74.36M |
| Revenue (ttm) | 8.58M |
| Net Income (ttm) | -78.43M |
| Shares Out | 271.99M |
| EPS (ttm) | -0.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 575,612 |
| Open | 0.260 |
| Previous Close | 0.264 |
| Day's Range | 0.260 - 0.277 |
| 52-Week Range | 0.200 - 0.650 |
| Beta | 1.43 |
| Analysts | Hold |
| Price Target | 0.35 (+28.02%) |
| Earnings Date | May 14, 2024 |
About ASXC
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscop... [Read more]
Financial Performance
In 2023, ASXC's revenue was $8.58 million, an increase of 21.02% compared to the previous year's $7.09 million. Losses were -$78.43 million, 3.80% more than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ASXC stock is "Hold." The 12-month stock price forecast is $0.35, which is an increase of 28.02% from the latest price.
News
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
Second System to be Utilized by one of the Largest Private Hospital Systems in Japan RESEARCH TRIANGLE PARK, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a me...
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device company that is digitizing the interface b...
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pa...
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pa...
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Office...
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program
The Fourth Hospital to Initiate a Senhance® Surgical System Dedicated to Pediatric Procedures The Fourth Hospital to Initiate a Senhance® Surgical System Dedicated to Pediatric Procedures
Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
RESEARCH TRIANGLE PARK, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient,...
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient,...
Asensus Announces Sale of Senhance Robotic System in Romania
Senhance® System to be placed at a pediatric hospital in Timisoara, Romania Senhance® System to be placed at a pediatric hospital in Timisoara, Romania
Senhance Robotic System Sold by Asensus Surgical
Senhance® System to be placed at a hospital in the Commonwealth of Independent States Senhance® System to be placed at a hospital in the Commonwealth of Independent States
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces Sale of Senhance Robotic System
Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program
RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical to Participate in the H.C. Wainwright 25th Annual Global Investment Conference and 2023 Cantor Global Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Offic...
Asensus Surgical Announces First Towakai Hospital in Japan to Initiate Senhance Surgery Program
RESEARCH TRIANGLE PARK, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 10, 2023
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces $10 Million Registered Direct Offering
RESEARCH TRIANGLE PARK, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device company that is digitizing the interface bet...
Asensus Surgical Announces Leading United States-Based Hospital to Initiate Senhance Surgery Program
Senhance® Surgical System to be Exclusively Utilized within the Pediatric Surgery Department Senhance® Surgical System to be Exclusively Utilized within the Pediatric Surgery Department
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2023
RESEARCH TRIANGLE PARK, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pa...